Study of Longidaze in the Prevention & Treatment of Pulmonary Fibrosis, Interstitial Lung Diseases Caused by COVID-19

Exhaled Breath Analysis Using eNose Technology as a Biomarker for Diagnosis and Disease Progression in Fibrotic ILD

NCT04680832 ·Status: ACTIVE_NOT_RECRUITING

Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions

NCT04987606 ·Status: COMPLETED

Integrating Molecular, Genomic, Morphology and Environmental Features to Improve Precision Diagnosis and Treatment in Interstitial Lung Diseases (PRECISION-ILD)

NCT05998512 ·Status: RECRUITING

FIBRotic Interstitial Lung Disease and Nocturnal OXygen

NCT04586946 ·Status: COMPLETED

The Clinical Value of the Nitric Oxide System Components in Asthma and COPD

NCT04456491 ·Status: UNKNOWN

Imaging Evaluation of PLN-74809 in Participants With IPF (PLN-74809)

NCT05621252 ·Status: COMPLETED ·Phase: PHASE2

Using Remote Telemonitoring to Detect Early Decline in Lung Function & Streamline Clinics in Adults With Cystic Fibrosis

NCT02399241 ·Status: COMPLETED ·Phase: NA

A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

NCT07245407 ·Status: RECRUITING

Impact of A. Lumbricoides on Pulmonary Aspergillosis Development

NCT05783544 ·Status: RECRUITING ·Phase: NA

Lung Structure-Function In Survivors of Mild and Severe COVID-19 Infection

NCT04584671 ·Status: ACTIVE_NOT_RECRUITING

Exhaled Breath Condensate Biomarkers and Cough in IPF

NCT02630940 ·Status: COMPLETED

Correlation Between Changes in Lung Function and Changes in Cough and Dyspnoea in Nintedanib-treated Connective Tissue Disease Interstitial Lung Disease (CTD-ILD) Patients

NCT05503030 ·Status: COMPLETED

PRospective Evaluation of Interstitial Lung DIsease Progression With Quantitative CT

NCT05609201 ·Status: ENROLLING_BY_INVITATION

INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

NCT04702893 ·Status: COMPLETED

Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device

NCT05145894 ·Status: UNKNOWN

A Study of the Natural Progression of Interstitial Lung Disease (ILD)

NCT00470327 ·Status: RECRUITING

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

NCT06323876 ·Status: RECRUITING

Pulmonary Fibrosis After Severe COVID-19 Pneumonia

NCT06423560 ·Status: COMPLETED

Follow-up Study of Autologous Transplantation of P63+ Lung Progenitor Cells for Treatment of Bronchiectasis

NCT06164093 ·Status: COMPLETED ·Phase: NA

Prospective Study of Fibrosis In the Lung Endpoints (PROFILE - Central England)

NCT01134822 ·Status: COMPLETED

Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

NCT02230982 ·Status: NO_LONGER_AVAILABLE

A Multicenter Prospective Study of Risk Factors in Progressive Pulmonary Fibrosis

NCT05895409 ·Status: RECRUITING

Exploration of Metabolome in Patients With Interstitial Lung Disease and Pulmonary Hypertension With or Without Specific Pulmonary Hypertension Treatment

NCT07254338 ·Status: RECRUITING

The Study Of Probe-Based Confocal Laser Endomicroscopy Of Distal Airways In Diagnostics Of Lung Diseases

NCT02006940 ·Status: UNKNOWN ·Phase: NA

Predictive Ability of the Chronic Obstructive Pulmonary Disease (COPD) Assessment Test (CAT) for Acute Exacerbations (PACE) in Patients With COPD

NCT01254032 ·Status: COMPLETED